BioMarin Pharmaceutical(BMRN) - 2023 Q4 - Earnings Call Transcript

Operator Luca Issi Given the relatively slow launch, is that still a plan? Or is there a scenario don't invest that capital, just you prioritize operational efficiency to really make the story here, driven primarily by VOXZOGO [indiscernible] and valrox any color there, much appreciated. We do intend to include a review of those studies in our portfolio assessment and prioritization. And so we'll communicate the plans for each of the additional potential Operator This concludes today's call. You may now dis ...